Search

Analysis of phage genomes replete with hypothetical genes is a challenge. Given the importance of genomic characterization of phages to understand their biology and for their safe use, International Bacteriophage Research Consortium (IBRC)

Phage enthusiasts need to take a 3-min break and watch this awesome student-made video breaking down phage lysogeny and the 'Piggyback the winner' hypothesis, set to the tune of a Justin Timberlake song... (no sound until around 0:26; then

Listen to soil phage ecologist Gary Trubl talk soil microbes and viral ecology on the Storytellers of STEMM podcast!

Viruses has an upcoming Special Issue on 'State-of-the-Art Phage Therapy Development in Europe'. They are looking for research articles, review articles and short communications related to: experimental and applied phage therapy; host–patho

FDA has cleared Adaptive Phage Therapeutics to start formally investigating use of its PhageBank™ to treat prosthetic joint infections. This gives APT the green light to start a phase 1/2 clinical trial in the first half of 2021 in collabor

Sabrina Green (Baylor College of Medicine) and colleagues published a new paper in MBio showing that a novel phage uses its tail fiber to bind to certain mammalian gut glycans, which helps it better target its host in the gut by localizing

Ruby Lin (Westmead Institute for Medical Research) and colleagues published a new paper in Current Opinion in Biotechnology detailing their vision for a nationally-networked approach to personalized phage therapy in Australia, based around

Fatma Abdelrahman (Zewail City of Science and Technology, Egypt) and colleagues from 7 countries (Egypt, India, Nigeria, Australia, China, Pakistan, Spain), many of them early career researchers, published a new review in Antibiotics on pha

Athina Zampara (University of Copenhagen, Denmark) and colleagues published a new paper in Frontiers in Microbiology on developing innolysins (endolysins fused to phage receptor binding proteins) against Campylobacter jejuni using a novel p

This week, we bring you an interview with Dr. Richard Alm, Alliance Director at CARB-X, a major current funder of new antimicrobials, including phage! Richard shares how he sees phages fitting into the clinical landscape, and shares his adv

In celebration of our 100th issue of Capsid & Tail, we launched a survey called State of Phage 2020! We created this survey to help us all better understand the phage research community globally, including what kind of phages people are col

ContraFect (Yonkers, NY), a clinical-stage biotechnology company focused on phage lysin development, is hiring a Director of Drug Product Development.

The Madsen lab at University of Copenhagen is hiring a postdoc to study how bacterial CRISPR-Cas immunity is regulated and controlled in response to environmental signals and extracellular factors. They aim to use this knowledge to manipula

The first Africa Phage Forum recording is now on YouTube! Catch Prof. Paul Turner's talk on phage therapy, from environment to bedside if you missed it! Great job organizers Emmanuel Nnadi & Angela Makumi of APF; it was a pleasure to collab

Dear iVoM participants, If you've attended at least two iVoM events, you're invited to participate in a contest! The contest aims at having the audience feedback regarding the iVoM: Viruses of Microbes 2020 Webinar Series: Take a walk on th

The sixth iVoM event will be Thursday, February 18, 11AM GMT (note time change!), and the theme will be "Biotechnology applications in health care". It will feature talks by: Laurent Debarbieux: Phages (in)action in the gut Krystyna Dabrows

The Center for Microbiome Science at Ohio State University is hosting a Microbiome Informatics webinar series, running from March to May 2021. Register here! This series represents a first phase effort to digitize 7 years of a hands-on info

As promised, the 24th biennial Evergreen International Phage Meeting will take place the first week of August 2021! Assuming it is safe to do so, the conference will be hosted in person on the Evergreen campus, in the dorms, as done in the

BiomX announced positive results of a Phase 1a phage pharmacokinetic study for inflammatory bowel disease/primary sclerosing cholangitis; they showed they could safely and successfully deliver phages to the gut. This was the first clinical

Aquaculture feed company Skretting and phage biotech company Proteon Pharmaceuticals are joining forces to trial phages to improve fish and shrimp health. Skretting will isolate strains of bacteria they'd like to target, and Proteon will de